• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

隆突性皮肤纤维肉瘤:148 例患者研究。

Dermatofibrosarcoma Protuberans: A Study of 148 Patients.

机构信息

Department of Dermatology, Hospital Universitari de Bellvitge, IDIBELL, Universitat de Barcelona, Barcelona, Spain.

Department of Plastic Surgery, Hospital Universitari de Bellvitge, IDIBELL, Universitat de Barcelona, Barcelona, Spain.

出版信息

Dermatology. 2024;240(3):487-493. doi: 10.1159/000536172. Epub 2024 Jan 16.

DOI:10.1159/000536172
PMID:38228098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11168446/
Abstract

INTRODUCTION

Dermatofibrosarcoma protuberans (DFSP) is the most common sarcoma of the skin. Although distant metastases are infrequent, DFSP is highly aggressive locally with frequent local recurrences. It has been reported that the presence within the tumour of areas histopathologically mimicking fibrosarcoma may increase the risk of recurrence.

OBJECTIVE

The objective of this study was to review the clinical features of our patients with DFSP and the factors associated with recurrence of the tumour, focussing on the presence of fibrosarcomatous areas.

METHODS

Retrospective study of patients with DFSP diagnosed in 1990-2021 in a tertiary university hospital. The medical records were reviewed to obtain the following data: age, sex, tumour location, diameter, evolution time, presence of fibrosarcomatous areas, development of recurrence, and follow-up. Factors possibly associated with disease-free survival were analysed with Kaplan-Meier method and multivariate Cox regression.

RESULTS

148 patients (74 women/74 men, mean age 46.28 years, SD 14.431) were included in the study. Tumours involved the head and neck in 15 cases, thorax in 31, abdomen in 16, upper back in 43, lower back in 10, upper extremities in 10, and lower extremities in 23. Fibrosarcoma-like areas were observed in 16 tumours (10.81%). In 17 patients (11.49%), recurrences were observed (13 local recurrences, 3 lung metastasis, and 1 local recurrence with lung metastasis). Fibrosarcomatous DFSP recurred more frequently than classic DFSP (50% vs. 6.82%, respectively), and its disease-free survival was significantly lower (p < 0.001). In multivariate Cox regression, the presence of fibrosarcomatous areas was the only factor influencing disease-free survival.

CONCLUSIONS

It is important to identify the fibrosarcomatous variant since it recurs more frequently and has lower recurrence-free survival. Distant metastases, mainly in the lung, are also more frequent in fibrosarcomatous DFSP.

摘要

简介

隆突性皮肤纤维肉瘤(DFSP)是最常见的皮肤肉瘤。虽然远处转移很少见,但 DFSP 在局部具有高度侵袭性,常发生局部复发。据报道,肿瘤内存在组织病理学上类似于纤维肉瘤的区域可能会增加复发的风险。

目的

本研究旨在回顾我们的 DFSP 患者的临床特征以及与肿瘤复发相关的因素,重点关注纤维肉瘤样区域的存在。

方法

回顾性分析 1990 年至 2021 年在一家三级大学医院诊断的 DFSP 患者的病历,以获取以下数据:年龄、性别、肿瘤位置、直径、演变时间、纤维肉瘤样区域的存在、复发的发展以及随访情况。使用 Kaplan-Meier 法和多变量 Cox 回归分析可能与无病生存相关的因素。

结果

研究共纳入 148 例患者(74 例女性/74 例男性,平均年龄 46.28 岁,标准差 14.431)。肿瘤发生于头部和颈部 15 例,胸部 31 例,腹部 16 例,上背部 43 例,下背部 10 例,上肢 10 例,下肢 23 例。16 例肿瘤中观察到纤维肉瘤样区域(10.81%)。17 例患者(11.49%)出现复发(13 例局部复发,3 例肺转移,1 例局部复发伴肺转移)。纤维肉瘤样 DFSP 比经典 DFSP 更频繁地复发(分别为 50%和 6.82%),其无病生存率显著降低(p < 0.001)。多变量 Cox 回归分析显示,纤维肉瘤样区域的存在是唯一影响无病生存率的因素。

结论

识别纤维肉瘤样变异体很重要,因为它更频繁地复发,且无复发生存率更低。纤维肉瘤样 DFSP 也更容易发生远处转移,主要是在肺部。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eded/11168446/984a19f9b157/drm-2024-0240-0003-536172_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eded/11168446/984a19f9b157/drm-2024-0240-0003-536172_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eded/11168446/984a19f9b157/drm-2024-0240-0003-536172_F01.jpg

相似文献

1
Dermatofibrosarcoma Protuberans: A Study of 148 Patients.隆突性皮肤纤维肉瘤:148 例患者研究。
Dermatology. 2024;240(3):487-493. doi: 10.1159/000536172. Epub 2024 Jan 16.
2
A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change.隆突性皮肤纤维肉瘤伴和不伴纤维肉瘤样变的结局数据的系统评价。
J Am Acad Dermatol. 2014 Oct;71(4):781-6. doi: 10.1016/j.jaad.2014.03.018. Epub 2014 Apr 19.
3
Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.纤维肉瘤样(“高级别”)隆突性皮肤纤维肉瘤:41例系列病例的临床病理及免疫组化研究,重点关注预后意义。
Am J Surg Pathol. 1998 May;22(5):576-87. doi: 10.1097/00000478-199805000-00009.
4
Dermatofibrosarcoma protuberans treated with wide local excision and followed at a cancer hospital: prognostic significance of clinicopathologic variables.在一家癌症医院接受广泛局部切除治疗并随访的隆突性皮肤纤维肉瘤:临床病理变量的预后意义
Am J Dermatopathol. 2012 Feb;34(1):24-34. doi: 10.1097/DAD.0b013e3182120671.
5
Analysis of surgical margins and prognostic factors in dermatofibrosarcoma protuberans after wide local excision: A multicenter study of 116 Japanese patients.广泛局部切除后隆突性皮肤纤维肉瘤的手术切缘和预后因素分析:116 例日本患者的多中心研究。
J Dermatol. 2024 Sep;51(9):1225-1232. doi: 10.1111/1346-8138.17280. Epub 2024 May 22.
6
Dermatofibrosarcoma protuberans with fibrosarcomatous areas: a clinico-pathologic and immunohistochemic study in four cases.伴有纤维肉瘤区域的隆突性皮肤纤维肉瘤:4例临床病理及免疫组化研究
Am J Dermatopathol. 1997 Dec;19(6):562-7. doi: 10.1097/00000372-199712000-00002.
7
Dermatofibrosarcoma protuberans with fibrosarcomatous areas. Molecular abnormalities of the p53 pathway in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.伴有纤维肉瘤区域的隆突性皮肤纤维肉瘤。隆突性皮肤纤维肉瘤纤维肉瘤转化过程中p53通路的分子异常。
Virchows Arch. 1998 Oct;433(4):323-9. doi: 10.1007/s004280050256.
8
[Fibrosarcomatous dermatofibrosarcoma protuberans: a clinicopathological analysis of 12 cases].[隆突性皮肤纤维肉瘤的纤维肉瘤样变型:12例临床病理分析]
Zhonghua Bing Li Xue Za Zhi. 2013 Nov;42(11):753-7.
9
From Morphea to Dermatofibrosarcoma Protuberans.从硬斑病到隆突性皮肤纤维肉瘤。
Acta Dermatovenerol Croat. 2022 Sep;30(2):113-115.
10
Dermatofibrosarcoma Protuberans: A Clinicopathologic and Therapeutic Analysis of 254 Cases at a Single Institution.隆突性皮肤纤维肉瘤:单中心 254 例的临床病理和治疗分析。
Dermatol Surg. 2021 Feb 1;47(2):e26-e30. doi: 10.1097/DSS.0000000000002578.

引用本文的文献

1
From skin to pancreas: The unusual path of fibrosarcomatous dermatofibrosarcoma protuberans - A rare case report.从皮肤到胰腺:隆突性皮肤纤维肉瘤的纤维肉瘤样不寻常病程——1例罕见病例报告
Int J Surg Case Rep. 2025 Jun;131:111337. doi: 10.1016/j.ijscr.2025.111337. Epub 2025 Apr 26.
2
Aesthetic Reconstruction of Secondary Wounds after Extended Resection of Dermatofibrosarcoma Protuberans: A Retrospective Study in One Center.隆突性皮肤纤维肉瘤扩大切除术后继发创面的美学修复:单中心回顾性研究
J Cosmet Dermatol. 2025 May;24(5):e70217. doi: 10.1111/jocd.70217.
3
Breast imaging findings in dermatofibrosarcoma protuberans: Case report and literature review.

本文引用的文献

1
Dermatofibrosarcoma Protuberans: A Clinicopathologic and Therapeutic Analysis of 254 Cases at a Single Institution.隆突性皮肤纤维肉瘤:单中心 254 例的临床病理和治疗分析。
Dermatol Surg. 2021 Feb 1;47(2):e26-e30. doi: 10.1097/DSS.0000000000002578.
2
Survival in patients with primary dermatofibrosarcoma protuberans: National Cancer Database analysis.原发性隆突性皮肤纤维肉瘤患者的生存情况:国家癌症数据库分析。
J Am Acad Dermatol. 2018 Jun;78(6):1125-1134. doi: 10.1016/j.jaad.2017.11.030. Epub 2017 Nov 23.
3
Wide local excision vs. Mohs Tübingen technique in the treatment of dermatofibrosarcoma protuberans: a two-centre retrospective study and literature review.
隆突性皮肤纤维肉瘤的乳腺影像学表现:病例报告及文献复习
Medicine (Baltimore). 2025 Apr 25;104(17):e42247. doi: 10.1097/MD.0000000000042247.
4
Congenital Dermatofibrosarcoma Protuberans-An Update on the Ongoing Diagnostic Challenges.先天性隆突性皮肤纤维肉瘤——当前诊断挑战的最新进展
Cancers (Basel). 2025 Jan 6;17(1):158. doi: 10.3390/cancers17010158.
广泛局部切除与莫氏蒂宾根技术治疗隆突性皮肤纤维肉瘤:一项两中心回顾性研究及文献复习。
J Eur Acad Dermatol Venereol. 2017 Dec;31(12):2069-2076. doi: 10.1111/jdv.14378. Epub 2017 Jul 3.
4
A Comparison of Mohs Micrographic Surgery and Wide Local Excision for Treatment of Dermatofibrosarcoma Protuberans With Long-Term Follow-up: The Mayo Clinic Experience.莫氏显微外科手术与广泛局部切除治疗隆突性皮肤纤维肉瘤的长期随访比较:梅奥诊所经验
Dermatol Surg. 2017 Jan;43(1):98-106. doi: 10.1097/DSS.0000000000000910.
5
Incidence and Survival of Primary Dermatofibrosarcoma Protuberans in the United States.美国原发性隆突性皮肤纤维肉瘤的发病率与生存率
Dermatol Surg. 2016 Jan;42 Suppl 1:S24-31. doi: 10.1097/DSS.0000000000000300.
6
Wide Local Excision for Dermatofibrosarcoma Protuberans: A Single-Center Series of 90 Patients.隆突性皮肤纤维肉瘤的广泛局部切除:单中心90例患者系列研究
Biomed Res Int. 2015;2015:642549. doi: 10.1155/2015/642549. Epub 2015 Nov 25.
7
Prognostic impact of fibrosarcomatous transformation in dermatofibrosarcoma protuberans: a cohort study.纤维肉瘤样转化对隆突性皮肤纤维肉瘤预后的影响:一项队列研究。
J Am Acad Dermatol. 2015 Mar;72(3):419-25. doi: 10.1016/j.jaad.2014.11.020. Epub 2015 Jan 10.
8
Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management.隆突性皮肤纤维肉瘤:诊断与治疗的全面综述及更新。
Semin Diagn Pathol. 2013 Feb;30(1):13-28. doi: 10.1053/j.semdp.2012.01.002.
9
Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.隆突性皮肤纤维肉瘤:一项关于低级别与高级别(纤维肉瘤样)肿瘤的临床病理、免疫组化、遗传学(COL1A1-PDGFB)和治疗研究。
J Am Acad Dermatol. 2011 Sep;65(3):564-575. doi: 10.1016/j.jaad.2010.06.020. Epub 2011 May 12.
10
Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays.当通过新开发的多重逆转录聚合酶链反应和荧光原位杂交检测法进行研究时,几乎在所有隆突性皮肤纤维肉瘤病例中都能鉴定出隆突性皮肤纤维肉瘤COL1A1-PDGFB融合基因。
Hum Pathol. 2008 Feb;39(2):184-93. doi: 10.1016/j.humpath.2007.06.009. Epub 2007 Oct 24.